Feature Channels:

All Journal News

Add to Favorites | Subscribe | Share

Filters:

  • (Press "esc" to clear)

Science

Channels:

Bacteria, Wastewater, Electrodes, Nanofibers, Sustainability, Pollutants

Bacteria-Coated Nanofiber Electrodes Clean Pollutants in Wastewater

Cornell University materials scientists and bioelectrochemical engineers may have created an innovative, cost-competitive electrode material for cleaning pollutants in wastewater.

Medicine

Channels:

Endocrine Society, Journal of Clinical Endocrinology and Metabolism , Obesity and Adolescents, Mortality, Cardiovascular Disease, Body Mass Index, Coronary Heart Disease

Adolescent Obesity Linked to Early Mortality From Cardiovascular Diseases

While there is solid evidence that adolescent overweight and obesity are associated with coronary heart disease (CHD) and stroke, less is known about the association between body mass index (BMI) and rarer cardiovascular diseases. A new large-scale, 45-year Israeli study published in the Endocrine Society’s Journal of Clinical Endocrinology & Metabolism found that higher BMI as well as BMI in the accepted normal range in late adolescence may be related to a higher risk of death in mid-adulthood from non-coronary non-stroke cardiovascular diseases such as fatal arrhythmia, hypertensive heart disease, cardiomyopathy, arterial disease, heart failure and pulmonary embolism.

Medicine

Channels:

EMBARGOED

A reporter's PressPass is required to access this story until the embargo expires on 3-Jul-2017 3:00 PM EDT

Medicine

Channels:

Researchers Propose New Approach to Identify Genetic Mutations in Men with Prostate Cancer

KATHLEENCOONEY_400.jpg

Scientists have had limited success at identifying specific inherited genes associated with prostate cancer. Researchers at University of Utah Health studied prostate cancer patients with multiple cancer diagnoses to identify genetic mutations that may influence cancer treatment and cancer risk.

Medicine

Channels:

Cancer, immune therapy, Antibody, Leukemia

New Antibody Appears to Re-Activate Immune System in Cancer Therapy

Adding an investigational antibody to the chemotherapy rituximab appears to restore its cancer-killing properties in certain leukemia patients with a natural resistance to the drug, according to a small, proof-of-concept study by Duke Cancer Institute researchers.

Medicine

Science

Channels:

Neuroscience, Neurology, Memory

EMBARGOED

A reporter's PressPass is required to access this story until the embargo expires on 5-Jul-2017 12:00 PM EDT

Medicine

Channels:

Cancer, Acute Myeloid Leukemia (AML), Stem Cell, Relapse, John Dick, leukemia stem cells, princess margaret cancer centre, University Health Network

Stem-Cell Researchers Solve Mystery of Relapse in Acute Myeloid Leukemia

Leukemia researchers led by Dr. John Dick have traced the origins of relapse in acute myeloid leukemia (AML) to rare therapy-resistant leukemia stem cells that are already present at diagnosis and before chemotherapy begins.

Life

Education

Channels:

big data analytics , Nepotism, nepotism in Italian academics, common names in scientific fields

EMBARGOED

A reporter's PressPass is required to access this story until the embargo expires on 3-Jul-2017 3:00 PM EDT

Science

Channels:

Water Management, soil, Hydrology, Drought, Flood

Calculating ‘Old’ and ‘New’ Water Runoff

IMG_4170.JPG

Researchers use equations and on-the-ground analyses to the follow water held in the soil versus fresh rainfalls. This can improve water management in drought- and flood-affected areas.

Medicine

Channels:

Hydrogel, Intracellular degradable, Poly(methacrylic acid), hydrophobic drug, BA-TPQ, Hepatocellular Carcinoma, Liver Cancer, Breast Cancer, Drug Delivery Systems

Micron-Sized Hydrogel Cubes Show Highly Efficient Delivery of a Potent Anti-Cancer Drug

Kharlampieva2016-scr1.jpg

Researchers have developed micro-cubes that can sponge up a hydrophobic anti-cancer drug and deliver it to cancer cells. Tissue culture tests show these tiny, porous cubes, loaded with the hydrophobic drug, are more potent against liver cancer cells and less harmful to normal liver cells.







Chat now!